Show simple item record

dc.contributor.authorGarcía Esquinas, E.
dc.contributor.authorOlmedo Palma, Pablo
dc.contributor.authorGil Hernández, Fernando 
dc.date.accessioned2021-03-08T09:42:11Z
dc.date.available2021-03-08T09:42:11Z
dc.date.issued2021-01
dc.identifier.citationGarcía-Esquinas, E., Carrasco-Rios, M., Ortolá, R., Prieto, M. S., Pérez-Gómez, B., Gutiérrez-González, E., ... & Rodríguez-Artalejo, F. (2020). S[elenium and impaired physical function in US and Spanish older adults. Redox biology, 38, 101819. [https://doi.org/10.1016/j.redox.2020.101819]es_ES
dc.identifier.urihttp://hdl.handle.net/10481/66970
dc.description.abstractBackground: Selenium (Se) is a trace element with a narrow safety margin. Objectives: To evaluate the cross-sectional and longitudinal dose-response association between Se exposure and measures of impaired physical function and disability in older adults. Design: NHANES 2011–2014 cross-sectional (US, n = 1733, age ≥60 years) and Seniors-ENRICA-2 2017–2019 cross-sectional and longitudinal (Spain, n = 2548 and 1741, respectively, age ≥65 years) data were analyzed. Whole blood and serum Se levels were measured using inductively coupled plasma-mass spectrometry. Lowerextremity performance was assessed with the Short Physical Performance Battery, and muscle weakness with a dynamometer. Incident mobility and agility limitations, and disability in instrumental activities of daily living (IADL) were ascertained with standardized questionnaires. Analyses were adjusted for relevant confounders, including physical activity. Results across studies were pooled using random-effects meta-analysis. Results: Meta-analyzed odds ratios (95% confidence interval) per log2 increase in whole blood Se were 0.54 (0.32; 0.76) for weakness, 0.59 (0.34; 0.83) for impaired lower-extremity performance, 0.48 (0.31; 0.68) for mobility limitations, 0.71 (0.45; 0.97) for agility limitations, and 0.34 (0.12; 0.56) for disability in at least one IADL. Analyses for serum Se in NHANES showed similar results. Findings suggest the inverse association with grip strength is progressive below 140 μg/L (p-value for non-linear trend in the Seniors-ENRICA-2 study = 0.13), and above 140 μg/L (p-value for non-linear trend in NHANES = 0.11). In the Seniors-ENRICA-2 cohort, with a 2.2 year follow-up period, a doubling in baseline Se levels were associated with a lower incidence of weakness [odds ratio (95% confidence interval): 0.45 (0.22; 0.91)], impaired lower-extremity performance [0.63 (0.32; 1.23)], mobility [0.43 (0.21; 0.91)] and agility [0.38 (0.18; 0.78)] limitations. Discussion: In US and Spanish older adults, Se concentrations were inversely associated with physical function limitations. Further studies are needed to elucidate underlying mechanisms.es_ES
dc.description.sponsorshipInstituto de Salud Carlos III European Commission PI18/287 16/609es_ES
dc.description.sponsorshipState Secretary of R + D + I PID2019-108973RB-C21/C22es_ES
dc.description.sponsorshipEuropean Social Fund (ESF) European Commissiones_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.subjectBiomarkerses_ES
dc.subjectDisabilityes_ES
dc.subjectOlder adultses_ES
dc.subjectPhysical performancees_ES
dc.subjectSelenium es_ES
dc.titleSelenium and impaired physical function in US and Spanish older adultses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.1016/j.redox.2020.101819
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Files in this item

[PDF]

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-SinDerivadas 3.0 España
Except where otherwise noted, this item's license is described as Atribución-NoComercial-SinDerivadas 3.0 España